Company intelligence / Profile preview

Optegra

London, England, United Kingdom

Ownership: Private
Employees: ~545
Development stage: Other

Overview

Optegra delivers high-volume, audited clinical care in ophthalmology with notable expertise in cataract surgery, vision correction, AMD, and other medical/surgical eye treatments. Their quality metrics (e.g., Trustpilot 4.8, Doctify 4.9) reflect strong outcomes; more than 1.3M lifetime procedures across the UK and Europe. No investigational drugs or clinical-stage pipeline.

Therapeutic areas: Ophthalmology
Modalities: Device (laser surgery equipment, intraocular lenses)Non-pharmacological therapy (surgical interventions)
Industry: Non-Academic Healthcare

Partnerships

NHS

Beyond the preview

Go deeper on Optegra.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optegra.

Explore the full profile